These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 28457731)
1. Expression pattern of cancer-associated fibroblast and its clinical relevance in intrahepatic cholangiocarcinoma. Zhang XF; Dong M; Pan YH; Chen JN; Huang XQ; Jin Y; Shao CK Hum Pathol; 2017 Jul; 65():92-100. PubMed ID: 28457731 [TBL] [Abstract][Full Text] [Related]
2. Elevated expression of G Cao XY; Ji HJ; Zhou YJ; Lu XF; Shen JY; Wu ZR; Bu H; Shi YJ Hepatobiliary Pancreat Dis Int; 2017 Dec; 16(6):638-644. PubMed ID: 29291784 [TBL] [Abstract][Full Text] [Related]
3. Isolation of cancer-associated fibroblasts and its promotion to the progression of intrahepatic cholangiocarcinoma. Sha M; Jeong S; Qiu BJ; Tong Y; Xia L; Xu N; Zhang JJ; Xia Q Cancer Med; 2018 Sep; 7(9):4665-4677. PubMed ID: 30062820 [TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical characterization of cancer-associated fibroblasts at the primary sites and in the metastatic lymph nodes of human intrahepatic cholangiocarcinoma. Itou RA; Uyama N; Hirota S; Kawada N; Wu S; Miyashita S; Nakamura I; Suzumura K; Sueoka H; Okada T; Hatano E; Tsutsui H; Fujimoto J Hum Pathol; 2019 Jan; 83():77-89. PubMed ID: 30172911 [TBL] [Abstract][Full Text] [Related]
5. Staging, prognostic factors and adjuvant therapy of intrahepatic cholangiocarcinoma after curative resection. Li T; Qin LX; Zhou J; Sun HC; Qiu SJ; Ye QH; Wang L; Tang ZY; Fan J Liver Int; 2014 Jul; 34(6):953-60. PubMed ID: 24134199 [TBL] [Abstract][Full Text] [Related]
6. STAT3 overexpression promotes metastasis in intrahepatic cholangiocarcinoma and correlates negatively with surgical outcome. Yang XW; Li L; Hou GJ; Yan XZ; Xu QG; Chen L; Zhang BH; Shen F Oncotarget; 2017 Jan; 8(5):7710-7721. PubMed ID: 28032598 [TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma. Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932 [TBL] [Abstract][Full Text] [Related]
8. Reduced expression of P120 catenin in cholangiocarcinoma correlated with tumor clinicopathologic parameters. Zhai B; Yan HX; Liu SQ; Chen L; Wu MC; Wang HY World J Gastroenterol; 2008 Jun; 14(23):3739-44. PubMed ID: 18595142 [TBL] [Abstract][Full Text] [Related]
10. Comparisons of cancer-associated fibroblasts in the intratumoral stroma and invasive front in colorectal cancer. Son GM; Kwon MS; Shin DH; Shin N; Ryu D; Kang CD Medicine (Baltimore); 2019 May; 98(18):e15164. PubMed ID: 31045759 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma. Wakai T; Shirai Y; Sakata J; Matsuda Y; Korita PV; Takamura M; Ajioka Y; Hatakeyama K Int J Clin Exp Pathol; 2011 Apr; 4(4):363-70. PubMed ID: 21577322 [TBL] [Abstract][Full Text] [Related]
12. Identification of Homer1 as a potential prognostic marker for intrahepatic cholangiocarcinoma. Wu SY; Yu MX; Li XG; Xu SF; Shen J; Sun Z; Zhou X; Chen XZ; Tu JC Asian Pac J Cancer Prev; 2014; 15(7):3299-304. PubMed ID: 24815486 [TBL] [Abstract][Full Text] [Related]
13. Prognosis after resection for hepatitis B virus-associated intrahepatic cholangiocarcinoma. Wu ZF; Wu XY; Zhu N; Xu Z; Li WS; Zhang HB; Yang N; Yao XQ; Liu FK; Yang GS World J Gastroenterol; 2015 Jan; 21(3):935-43. PubMed ID: 25624728 [TBL] [Abstract][Full Text] [Related]
14. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma. Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558 [TBL] [Abstract][Full Text] [Related]
15. Analysis of cancer-associated fibroblasts and the epithelial-mesenchymal transition in cutaneous basal cell carcinoma, squamous cell carcinoma, and malignant melanoma. Sasaki K; Sugai T; Ishida K; Osakabe M; Amano H; Kimura H; Sakuraba M; Kashiwa K; Kobayashi S Hum Pathol; 2018 Sep; 79():1-8. PubMed ID: 29555579 [TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma. Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841 [TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic value of PRL-3 in human intrahepatic cholangiocarcinoma. Xu Y; Zhu M; Zhang S; Liu H; Li T; Qin C Pathol Oncol Res; 2010 Jun; 16(2):169-75. PubMed ID: 19757198 [TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition phenotypes are associated with patient survival in intrahepatic cholangiocarcinoma. Gu MJ; Choi JH J Clin Pathol; 2014 Mar; 67(3):229-34. PubMed ID: 24062361 [TBL] [Abstract][Full Text] [Related]
19. Osteopontin promoter polymorphisms at locus -443 are associated with metastasis and poor prognosis of human intrahepatic cholangiocarcinoma in Chinese population. Zhao XQ; Ma HX; Su MS; He L Int J Clin Exp Pathol; 2014; 7(10):6914-21. PubMed ID: 25400775 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of FAP-α on microvessel and lymphatic vessel density in lung squamous cell carcinoma. Chen L; Chen M; Han Z; Jiang F; Xu C; Qin Y; Ding N; Liu Y; Zhang T; An Z; Guo C J Clin Pathol; 2018 Aug; 71(8):721-728. PubMed ID: 29559517 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]